Business Insider

Insignis Therapeutics and HLK Pharmacin Receive FDA IND Clearance to Initiate a Phase 1 Trial With IN-001 for Oral Anaphylaxis Treatment

Trial to initiate this quarter with data anticipated in 2021 Convenient oral alternative to injectable epinephrine NORTH HAVEN, Conn. and NEW HAVEN, Conn., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Insignis ...
Yahoo Finance

Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis

Rapid epinephrine absorption with a time to reach the 100 pg/mL threshold concentration in 9 minutes after dosing Sustained pharmacokinetics (PK) with plasma epinephrine concentration remaining above ...
Business Insider

Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment

NORTH HAVEN, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Insignis Therapeutics, a pharmaceutical company focused on developing innovative allergy and anaphylaxis treatments, is pleased to announce that ...
Moviefone

Insignis - Where to Watch

In the mood for 'Insignis' tonight? Searching for where to stream, rent, buy, or watch where to stream or rent the Jonathan Sarmiento directed movie can be harder than it should be so we at Moviefone ...
Yahoo Finance

Insignis Therapeutics and HLK Pharmacin Receive FDA IND Clearance to Initiate a Phase 1 Trial With IN-001 for Oral Anaphylaxis Treatment

NORTH HAVEN, Conn. and NEW HAVEN, Conn., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Insignis Therapeutics (“Insignis”), a biotech company focused on developing innovative therapeutics for anaphylaxis treatment ...